Modern methods for the treatment of gastritis in dogs

The work has studied that tylosin is the drug of choice in the treatment of acute and chronic enteropathies in dogs, and has a successful application in practical veterinary medicine. Based on the results of the study, it can be concluded that with signs of a weak degree of inflammation, the number of all dogs with gastritis is one third, which occupies a significant place among all animals who have applied to the clinic. But also, it should be noted that the main component - half of the cases - falls on patients with an average degree of inflammation of the digestive canal, which is why it requires a detailed study of this particular group of sick pets. This group included dogs with leukocytosis in the general blood test within the reference values of 10-16 x 109/l. In this group, we tested the use of the drug tylosin as the main therapeutic drug, since this group accounted for the largest percentage of the total number. Thus, we came to the conclusion that tylosin is the drug of choice in the treatment of acute and chronic enteropathies in dogs, in monotherapy at the initial stages of the disease, and in complex therapy with intensive treatment, as an additional antibacterial drug that has been successfully used in veterinary non-infectious therapy of small pets. And also noted its successful use on a long-term basis in chronic enteropathies, including with enteral administration, which does not make it difficult for owners to use.